Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(16 sites)
France
Angers University Hospital, Angers Avicenne University Hospital, Bobigny University Hospital, Clermont-Ferrand, Clermont-Ferrand Louis Mourier Hospital, Colombes University Hospital, Grenoble, Grenoble Nancy University Hospital, Nancy Nantes University Hospital, Nantes Nice University Hospital, Nice La Pitié Salpêtrière University Hospital, Paris Lariboisiere Hospital, Paris Saint Antoine University Hospital, Paris Poitiers University Hospital, Poitiers Rennes University Hospital, Rennes Strasbourg University Hospital, Strasbourg Tours University Hospital, Tours